• Register
  • Login
  • Subscribe
  • Contact Us

Live Attenuated Influenza Vaccine (Laiv) 2023-2024 and Options (2024-2025, 2025-2026, 2026-2027)

FinlandTenders notice for Live Attenuated Influenza Vaccine (Laiv) 2023-2024 and Options (2024-2025, 2025-2026, 2026-2027). The reference ID of the tender is 73858500 and it is closing on 01 Dec 2022.

Tender Details

  • Country: Finland
  • Summary: Live Attenuated Influenza Vaccine (Laiv) 2023-2024 and Options (2024-2025, 2025-2026, 2026-2027)
  • FIT Ref No: 73858500
  • Deadline: 01 Dec 2022
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 600779-2022
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or β€œCustomer” ) request your tender for Live Attenuated Influenza Vaccine (LAIV) belonging to the National Vaccination Programme in Finland. The contract period is one year (influenza season 2023-2024). The procurement contains three options to extend the contract for the periods concerning influenza seasons 2024-2025, 2025-2026 and 2026-2027. Estimated quantity for the contract period including options is 464.000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. Please note that all times given in the Call for tender refer to local time in Finland. Call for Tenders Annexes: Annex 1 Contract Live Attenuated influenza Vaccine (LAIV) Annex 2 JYSE 2014 Supplies (updated version of April 2022) Annex 3 Handi Service
    Doc Title: Vaccines
    Contract Type: Supplies
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Live Attenuated Influenza Vaccine (Laiv) 2023-2024 and Options (2024-2025, 2025-2026, 2026-2027) - Finland Tender

The MINISTRY OF SOCIAL AFFAIRS AND HEALTH, a Government sector organization in Finland, has announced a new tender for Live Attenuated Influenza Vaccine (Laiv) 2023-2024 and Options (2024-2025, 2025-2026, 2026-2027). This tender is published on FinlandTenders under FIT Ref No: 73858500 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-12-01.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

FinlandTenders Features

FinlandTenders Features

Fresh and verified Tenders from Finland. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting FinlandTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Finland in your email inbox.

  Chat with us